STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Medpace Holdings, Inc. (Nasdaq: MEDP) has announced its participation in the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:00 a.m. ET. The event will feature key executives including August Troendle, President & CEO, and Jesse Geiger, CFO & COO. Investors can access the live webcast through the company’s website, with a replay available post-event. Medpace specializes in full-service clinical contract research, focusing on accelerating the development of safe medical therapeutics in various therapeutic areas.

Positive
  • None.
Negative
  • None.

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference:

Jefferies Virtual Healthcare Conference
Date: Wednesday, June 2, 2021
Presentation: 9:00 a.m. ET
Speakers: August Troendle, President & Chief Executive Officer, Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations, and Kevin Brady, Executive Director of Finance

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,900 people across 40 countries as of March 31, 2021.

FAQ

When will Medpace Holdings present at the Jefferies Virtual Healthcare Conference?

Medpace Holdings will present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:00 a.m. ET.

Who are the speakers representing Medpace at the upcoming conference?

The speakers from Medpace will include August Troendle, President & CEO, Jesse Geiger, CFO & COO, and Kevin Brady, Executive Director of Finance.

How can investors access the Medpace conference presentation?

Investors can access the live webcast of the Medpace conference presentation through the ‘Investors’ section of Medpace’s website.

What is the primary focus of Medpace's clinical research services?

Medpace provides Phase I-IV clinical development services, focusing on accelerating the global development of safe and effective medical therapeutics across various therapeutic areas.

Where is Medpace Holdings headquartered?

Medpace Holdings is headquartered in Cincinnati, Ohio.

Medpace Holdings, Inc.

NASDAQ:MEDP

MEDP Rankings

MEDP Latest News

MEDP Stock Data

10.54B
25.52M
17.78%
85.95%
3.54%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States of America
CINCINNATI